Universe Pharmaceuticals Inc (UPC)
2.15
-0.02
(-0.92%)
USD |
NASDAQ |
May 03, 16:00
2.03
-0.12
(-5.58%)
After-Hours: 20:00
Universe Pharmaceuticals Debt to Equity Ratio: 0.1387 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.1387 |
| March 31, 2023 | 0.0865 |
| September 30, 2022 | 0.0848 |
| March 31, 2022 | 0.0721 |
| September 30, 2021 | 0.0735 |
| Date | Value |
|---|---|
| March 31, 2021 | 0.0542 |
| September 30, 2020 | 0.1272 |
| March 31, 2020 | 0.1453 |
| September 30, 2019 | 0.2036 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0542
Minimum
Mar 2021
0.2036
Maximum
Sep 2019
0.1095
Average
0.0865
Median
Mar 2023
Debt to Equity Ratio Benchmarks
| Sinovac Biotech Ltd | 0.0292 |
| CASI Pharmaceuticals Inc | 0.7819 |
| Zai Lab Ltd | 0.00 |
| I-MAB | 0.0517 |
| Gracell Biotechnologies Inc (DELISTED) | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 53.29M |
| Total Liabilities (Quarterly) | 13.75M |
| Shareholders Equity (Quarterly) | 39.53M |
| Current Ratio | 2.676 |
| Net Debt Paydown Yield | -10.32% |